0001415889-18-001565.txt : 20181031 0001415889-18-001565.hdr.sgml : 20181031 20181031160017 ACCESSION NUMBER: 0001415889-18-001565 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181029 FILED AS OF DATE: 20181031 DATE AS OF CHANGE: 20181031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alles Mark J CENTRAL INDEX KEY: 0001538897 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 181150248 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-10312018_041001.xml X0306 4 2018-10-29 0000816284 CELGENE CORP /DE/ CELG 0001538897 Alles Mark J C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 true true false false CEO, CHAIRMAN OF BOARD Stock Option (right to buy) 71.43 2018-10-29 4 A 0 59234 0 A 2028-10-29 Common Stock 59234 59234 D Option is immediately exercisable and will vest in four equal annual installments commencing on October 29, 2019. The option was issued pursuant to the Company's 2017 Stock Incentive Plan. /s/ Mark J. Alles 2018-10-31